University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Microbiology Publications and Other Works

Microbiology

April 2011

Comparison of human optimized bacterial luciferase, firefly
luciferase, and green fluorescent protein for continuous imaging
of cell culture and animal models
Dan M. Close
Ruth E. Hahn
Stacey S. Patterson
Seung J. Baek
Steven Ripp
University of Tennessee - Knoxville, saripp@utk.edu

See next page for additional authors

Follow this and additional works at: https://trace.tennessee.edu/utk_micrpubs
Part of the Biotechnology Commons

Recommended Citation
Close, Dan M.; Hahn, Ruth E.; Patterson, Stacey S.; Baek, Seung J.; Ripp, Steven; and Sayler, Gary S.,
"Comparison of human optimized bacterial luciferase, firefly luciferase, and green fluorescent protein for
continuous imaging of cell culture and animal models" (2011). Microbiology Publications and Other
Works.
https://trace.tennessee.edu/utk_micrpubs/38

This Article is brought to you for free and open access by the Microbiology at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Microbiology Publications and Other Works by an
authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please
contact trace@utk.edu.

Authors
Dan M. Close, Ruth E. Hahn, Stacey S. Patterson, Seung J. Baek, Steven Ripp, and Gary S. Sayler

This article is available at TRACE: Tennessee Research and Creative Exchange: https://trace.tennessee.edu/
utk_micrpubs/38

Comparison of human optimized
bacterial luciferase, firefly luciferase, and
green fluorescent protein for continuous
imaging of cell culture and animal models
Dan M. Close
Ruth E. Hahn
Stacey S. Patterson
Seung J. Baek
Steven A. Ripp
Gary S. Sayler

Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 05/29/2013 Terms of Use: http://spiedl.org/terms

Journal of Biomedical Optics 16(4), 047003 (April 2011)

Comparison of human optimized bacterial luciferase,
firefly luciferase, and green fluorescent protein for
continuous imaging of cell culture and animal models
Dan M. Close,a Ruth E. Hahn,a Stacey S. Patterson,a Seung J. Baek,b Steven A. Ripp,a and Gary S. Saylera
a University

of Tennessee, Center for Environmental Biotechnology, 1414 Circle Drive, 676 Dabney Hall, Knoxville,
Tennesssee 37996
b University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, Tennessee 37996

Abstract. Bioluminescent and fluorescent reporter systems have enabled the rapid and continued growth of the
optical imaging field over the last two decades. Of particular interest has been noninvasive signal detection from
mammalian tissues under both cell culture and whole animal settings. Here we report on the advantages and
limitations of imaging using a recently introduced bacterial luciferase (lux) reporter system engineered for increased bioluminescent expression in the mammalian cellular environment. Comparison with the bioluminescent
firefly luciferase (Luc) system and green fluorescent protein system under cell culture conditions demonstrated
a reduced average radiance, but maintained a more constant level of bioluminescent output without the need
for substrate addition or exogenous excitation to elicit the production of signal. Comparison with the Luc system
following subcutaneous and intraperitoneal injection into nude mice hosts demonstrated the ability to obtain
similar detection patterns with in vitro experiments at cell population sizes above 2.5 × 104 cells but at the cost of
increasing overall image integration time. C 2011 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.3564910]
Keywords: bacterial luciferase; firefly luciferase; green fluorescent protein; optical imaging; bioluminescence.
Paper 10637R received Dec. 2, 2010; revised manuscript received Feb. 18, 2011; accepted for publication Feb. 21, 2011; published
online Apr. 7, 2011.

1 Introduction
We have recently demonstrated that autonomous bioluminescent production from a mammalian cell line expressing humanoptimized (ho) bacterial luciferase (lux) cassette genes can be
used as a target for cell culture and small animal bioluminescent imaging.1 Here we compare the bioluminescent expression
of a mammalian HEK293 cell line transfected with the holux
genes with the bioluminescent expression of the same cell line
expressing a commercially available, ho-firefly luciferase gene
(luc) and the fluorescent expression of a commercially available,
improved green fluorescent protein (GFP). luc and gfp are two
of the most widely known and used reporter genes for optical
imaging2 and therefore provide excellent points of comparison
for determining if holux expression would be beneficial in a
given experiment.
The three systems are intrinsically different, and as such, have
the potential to fulfill alternative niches within the needs of the
bioimaging community. The holux system is unique among bioluminescent systems because of its ability to autonomously synthesize and/or scavenge all required substrates from the host cell
in order to produce bioluminescence in a fully autonomous fashion. The system itself is composed of five genes with the luxA
and luxB gene products forming the heterodimeric luciferase
enzyme and the luxD, luxC, and luxE gene products forming a
transferase, a synthase, and a reductase, respectively, that work
together to produce and regenerate the required myristyl aldehyde co-substrate from endogenous myristyl groups. A sixth
Address all correspondence to: Gary Sayler, University of Tennessee, Knoxville,
Center for Environmental Biotechnology, 1414 Circle Drive, 676 Dabney Hall,
Knoxville, Tennessee 37996. Tel: 865 974 8080; E-mail: sayler@utk.edu.
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gene, frp, encodes an NAD(P)H:flavin reductase that helps to cycle endogenous flavin mononucleotide (FMN) into the required
FMNH2 co-substrate. Along with molecular oxygen, these components supply the enzyme with all the required products to
produce a bioluminescent signal at 490 nm.3
The Luc system catalyzes the oxidation of reduced luciferin
in the presence of ATP-Mg2 + and oxygen to generate CO2 ,
AMP, PPi , oxyluciferin, and yellow-green light at a wavelength
of 562 nm. This reaction was originally reported to occur with
a quantum yield of 0.88,4 but has since been shown to actually
achieve a quantum yield closer to only 0.41.5 The Luc system used in these experiments utilizes a commercially available
holuc gene from the Promega Corporation (luc2). This gene encodes for an altered protein that improves translational efficiency
in the mammalian cellular background and has also been destabilized to promote lower background and increased induction
levels.6
The GFP system is perhaps one of the most well characterized and longest studied of any reporter system available.7 It
differs from the holux and Luc systems in that it is a fluorescent reporter. The oxidized GFP protein, upon excitation at 395
or 478 nm, produces a fluorescent emission signal at 507 nm,
allowing for detection. These experiments use an improved gfp
gene that is commercially available from Invitrogen. This version of gfp has been optimized for higher levels of solubility and
greater than 40-fold increase in fluorescent yield over the wildtype GFP protein.8 Despite these engineered improvements, the
requisite excitation signal for this, like the majority of GFPvariants, elicits high levels of background fluorescence under
C 2011 SPIE
1083-3668/2011/16(4)/047003/10/$25.00 
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small animal imaging conditions.2, 9 In this respect, it will be
tested only under cell culture conditions, since its use in small
animal imaging is becoming increasingly supplanted by proteins or dyes that emit light in the near infrared range where
autofluorescence and absorption levels are lower.10
The Luc and GFP imaging targets are representative of the
types of reporter systems commonly employed in the optical
imaging community11 and provide well known benchmarks
against which to compare the bioluminescent expression of the
new holux system. Here we compare the luminescent profile
and intensity of holux-expressing HEK293 cells with the luminescent and fluorescent profiles and intensities of HEK293 cells
expressing the human optimized Luc and improved GFP systems
in cell culture and the holux and Luc bioluminescent systems
under small animal imaging conditions. The shape and duration
of the resulting light signals over time are compared, as are respective signal intensities and minimum detectable reporter cell
numbers to establish which type of reporter system may be most
appropriate under a given set of imaging conditions.

2 Experimental
2.1 Transfection and Selection of Cell Lines
Transfection was carried out in six-well Falcon tissue culture
plates (Thermo-Fisher, Pittsburgh, Pennsylvania). HEK293 cells
were passaged into each well at a concentration of ∼4 × 105
cells/well in complete medium the day before transfection. Plasmid vectors were purified from 100 ml overnight cultures of
E. coli using the Wizard Purefection plasmid purification system (Promega, Madison, Wisconsin). On the day of transfection,
cell medium was removed and replaced and vector DNA was introduced using Lipofectamine 2000 (Invitrogen, Carlsbad, California). Twenty-four hours post-transfection, the medium was
removed and replaced with complete medium supplemented
with the appropriate antibiotic. Selection of successfully transfected clones was performed by refreshing selective medium
every 4 to 5 days until all untransfected cells had died. At
this time, colonies of transfected cells were removed by scraping, transferred to individual 25 cm2 cell culture flasks, and
grown in complete medium supplemented with the appropriate
antibiotics.

2.2 In Vitro Imaging
Actively growing HEK293 cells expressing either
pLuxCDEfrp :CO/pLuxAB (holux), pGL4.50[luc2/CMV/Hygro]
(Luc), or pCDNA3.1-CT-GFP (GFP) were trypsinized and
harvested from 75 cm2 tissue culture flasks and viable cell
counts were determined as the average of two counts using a
hemocytometer. Serial dilutions of cells ranging from ∼1 ×
106 cells per well to ∼100 cells per well were plated in each of
three wells in opaque 24-well tissue culture plates in DMEM
without phenol red and supplemented with 10% fetal bovine
serum, 0.01 millimolar (mM) nonessential amino acids, and
0.01 mM sodium pyruvate. Because of the autofluorescent
nature of mammalian tissues, HEK293 cells expressing GFP
were subjected to alternate conditions to better elucidate
the GFP-based fluorescent signal from tissue autofluorescent
background. Along with all surveyed cell population sizes, an
Journal of Biomedical Optics

equal number of untransfected HEK293 cells were plated to
determine autofluorescent levels from each population size.
In addition, cells were plated in phosphate buffered saline
(PBS) to reduce background fluorescent detection from the
medium. All values were reported as background corrected
averages, which were obtained by subtracting the measured
autofluorescent background value from the average fluorescent
flux of each cell population size. For Luc-expressing cell lines,
all wells were spiked with 0.07 mg D-luciferin/ml (Caliper
Life Sciences, Hopkinton, MA) immediately before imaging.
In all assays a sample of medium without cells present was
included to determine the level of background detection. Photon
counts were recorded using an IVIS Lumina in vivo imaging
system and analyzed with Living Image 3.0 software (Caliper
Life Sciences, Hopkinton, Massachusetts). To determine
the change in light output over time, average radiance for
population sizes of ∼1 × 106 cells was determined in photons
(p)/s/cm2 /steridian (sr) for each well using integration times
of 10 min (holux), 10 s (Luc), or 1 s (GFP) and reported
as the average of three runs with the standard error of the
mean. Following initial analysis, the minimal detectable cell
number was determined by performing a second assay using
cell concentrations ranging between the lowest detectable
number of the initial assay and the highest undetectable number
of cells plated and comparing the average radiance of each
population to the level of background light detected over
cell-free medium. For all measurements, statistical differences
were determined by using student’s t tests with a p value
cutoff of p = 0.05.

2.3 In Vivo Bioluminescent Imaging
All animal work was performed in adherence to the institutional
guidelines put forth by the animal care and use committee of the
University of Tennessee. All animal research procedures were
approved by the University of Tennessee Animal Care and Use
Committee (protocol number 1411) and were in accordance with
National Institutes of Health guidelines.
Five week old nu/nu (nude) mice (NCRNU-M, Taconic
Farms Inc., New York) were anesthetized via isoflurane inhalation until unconscious. Subcutaneous injections were performed in both the shoulder and hip of each subject (n = 3)
for a total of n = 6 subcutaneous injections for each cell line
tested. Subjects receiving holux cells were injected with ∼5 ×
106 cells. Subjects receiving Luc cells were injected with ∼5
× 105 cells. Cell counts were determined as the average of two
counts using a hemocytometer. All injections were performed in
a 100 μl volume of PBS. Due to the of the lack of endogenous
bioluminescent processes in mammalian tissue, and to control
for changes in overall animal size and dispersion of reportertagged cells following injection, readings were gathered as total
flux values and presented in photons (p)/second (s). Luc treated
subjects were immediately imaged following intraperitoneal injection of 150 mg D-luciferin/kg using a 1 s integration time,
whereas holux treated subjects were immediately imaged following the injections using 1 min integration times. Total flux
from each injection site was determined by drawing regions
of interest (ROI) of identical size over each location. Readings
were recorded over a 60 min period to determine the change in
flux over time.
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Fig. 1 Pseudocolor representation of the bioluminescent or fluorescent flux from cell concentrations ranging from 1 million (1M) to several thousand
(K) to approximately single cell levels (NEG = negative control wells) stably transfected with (a) holux, (c) Luc, or (e) GFP. Red lines indicate the
combination of two separate runs, each represented by the corresponding color scale on the right or left side of the figure. The yellow box in (e)
indicates wells containing equal numbers of untransfected HEK293 cells to determine levels of background autofluorescence. Note that autoscaling
of the pseudocolor image assigns brighter colors and larger areas to the larger population sizes of low level detection experiments although their
scale indicates overall lower levels of flux compared to larger population sizes. Average bioluminescent or fluorescent flux dynamics for the (b)
holux, (d) Luc, and (f) GFP-containing cell populations of ∼1 × 106 cells over a 24 hr period demonstrate the differences in signal intensity over
time.

To measure bioluminescent flux following intraperitoneal
injection of the cell lines, each subject (n = 2) received a
single injection of ∼1 × 106 cells (Luc) or ∼1 × 107 cells
(holux). All injections were performed in a 100 μl volume of
PBS. Luc treated subjects were immediately imaged following intraperitoneal injection of 150 mg D-luciferin/kg using a
10 s integration time and holux treated subjects were immediately imaged following injection using 1 min integration times.
Total flux from each subject was determined by drawing an
ROI of identical size over the animal. Readings were recorded
over a 60 min period to determine the change in flux over
time.
To determine the minimal detectable number of cells in vivo,
a subject was subcutaneously injected at three locations – the
scruff of the neck, the mid back, and hip – with the relevant
range of cells as determined by the previously described in vitro
minimum detectable cell number assays in a 100 μl volume of
PBS. Subjects were then imaged using integration times of up
to 10 min to determine if a luminescent signal could be detected
above background at the injected concentration of cells. For all
measurements, statistical differences were determined by using
student’s t tests with a p value cutoff of p = 0.05.

tration of ∼1 × 104 cells/well, however, this was determined
not to be significantly distinguishable from background (p =
0.72) in the given experiment (Fig. 2). In general, detection of
lower cell populations as significantly different than background
was more feasible at time points further from the initial plating
(Table 1). The luminescent profile of holux expression demonstrated a consistent increase in average radiance from an initial post-plating value of 1800 p/s/cm2 /sr to a peak of 6400
p/s/cm2 /sr 16 hr post-plating [Fig. 1(b)]. Following peak bioluminescence, the cells expressed a slow decrease in average
radiance over the remainder of the 24 hr assay, averaging a
reduction of 135 ( ± 16) p/s/cm2 /sr per hr. Expression was consistent over the course of the assay with the standard error of
the mean averaging 58 ( ± 4) p/s/cm2 /sr at each time point
surveyed.

Table 1 Larger population sizes of lux-expressing cells were visible
sooner following plating. Green boxes represent time points where
the indicated cell population was significantly distinguishable from
the background. Red hatched boxes represent time points where the
indicated cell population was not significantly distinguishable from
background light detection.

3 Results
3.1 In Vitro Holux Detection
Cells expressing the holux cassette genes produced a visible
light signal over a range from approximately 1 × 106 to 1.5
× 104 cells/well using a 10 min integration time [Fig. 1(a)]. A
detectable light signal was inconsistently observed at a concenJournal of Biomedical Optics

047003-3

Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 05/29/2013 Terms of Use: http://spiedl.org/terms

April 2011 r Vol. 16(4)

Close et al.: Comparison of human optimized bacterial luciferase...
Table 2 Larger populations of Luc-expressing cells were visible over
longer periods of time following the addition of D-luciferin. Due to
the highly dynamic nature of Luc expression, readings are reported
at 30 min intervals. Green boxes represent time points where the indicated cell population was significantly distinguishable from background. Red hatched boxes represent time points where the indicated
cell population was not significantly distinguishable from background
light detection.

cells compared to holux was a larger standard error. The average
error over the course of the Luc luminescence assay was 2.9 ( ±
0.6) × 106 p/s/cm2 /sr [Fig. 1(d)].

3.3 In Vitro GFP Detection

Fig. 2 Despite presenting an intermittently detectable pseudocolor image, a population of ∼10000 holux-expressing cells could not be statistically differentiated from background light detection. Boxes represent
the mean values of three trials, reported with overlapping standard
error of the means.

3.2 In Vitro Luc Detection
Cells expressing the human-optimized luc2 gene displayed a
significantly greater average radiance (p < 0.01) than those expressing the human-optimized lux genes and as a result were
visible at lower cell concentrations. Luc-expressing cells produced a visible signal over a range from ∼1 × 106 down to
2.5 × 102 cells/well at an integration time of 1 s [Figs. 1(c)
and 3(a)]. Although concentrations as low as 50 cells/well could
be differentiated from background if the integration time was
extended to 10 s [Fig. 3(b)], this concentration of cells was not
determined to be statistically greater than background light detection (p = 0.65) while using the 1 s integration time required to
prevent saturation of the camera at the higher cell concentrations
[Fig. 3(a)]. Detection of the Luc-tagged cell populations showed
the opposite trend of those expressing the holux genes and was
generally easier to differentiate from background at time points
closer to luciferin addition (Table 2). The luminescent profile of
the Luc-expressing cells displayed a large initial intensity, with
a peak average radiance of 8.9 ( ± 0.4) × 107 p/s/cm2 /sr 10
min following addition of 0.07 mg D-luciferin/ml. This level of
radiance was not maintained, however, and had decreased to 3.0
( ± 0.3) × 107 p/s/cm2 /sr by 40 min post-addition. The decrease
in radiance occurred during the period 10 to 30 min post-addition
of substrate, after which the signal remained steady ( ± 9.3
× 105 p/s/cm2 /sr) for the remainder of the assay. Concurrent
with the higher bioluminescent output of the Luc-expressing
Journal of Biomedical Optics

Fluorescent detection from GFP emission presented the least
sensitive lower limits of detection for any of the three reporter
systems tested when PBS was used as the assay medium. Under these conditions, detection ranged from ∼1 × 106 down
to 5 × 105 cells/well [Fig. 1(e)]. Although wells of less than
∼5 × 105 cells/well clearly show fluorescent signals, they were
not significantly different from background following subtraction of background tissue autofluorescence (Fig. 4). Similar to
the holux-expressing cells, detection ability increased for the
smaller population sizes over the course of the assay (Table 3).
Average radiance increased slightly but not significantly (p =
0.08) over the course of the assay from an initial value of 6.0
( ± 0.06) × 106 p/s/cm2 /sr to a peak of 6.6 ( ± 0.07) × 106
p/s/cm2 /sr by 22 hr after the initial plating. Over the full course
of the assay the average radiance remained relatively steady at
6.2 ( ± 0.05) × 106 p/s/cm2 /sr with an average error of 7.3 ( ±
0.3) × 104 p/s/cm2 /sr [Fig. 1(f)]. A full comparison of the pertinent expression data for all three reporter systems is detailed
in Table 4.

3.4 In Vivo Holux Detection
Average flux from subcutaneous injection of ∼5 × 106 holuxexpressing cells was 1.5 ( ± 0.2) × 105 p/s and remained relatively constant over the full course of the 60 min assay, displaying a minimum flux of 1.3 ( ± 0.1) × 105 p/s and a maximum of
1.5 ( ± 0.2) × 105 p/s. The standard errors of the readings were
relatively low, averaging 1.6 ( ± 0.3) × 104 p/s and therefore
provided readings with increased resolution compared to the
Luc reporter system. Over the full course of the assay, the bioluminescent profile remained relatively flat, displaying a range
of 2.8 × 104 p/s between the lowest and highest recorded values
[Fig. 5(a)]. To obtain a representative pseudocolor image during acquisition, integration times of 1 min were used, however,
we have previously demonstrated detection following subcutaneous injection of ∼5 × 106 holux-expressing cells is possible
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Fig. 3 Short integration times (∼1 s) are required to prevent saturation of the CCD camera when using a Luc-based reporter system due to its high
levels of bioluminescent flux following D-luciferin amendment. (a) However, at integration times of 1 s it is not possible to differentiate Luc-expressing
cell populations below ∼250 cells from background light detection. (b) Increasing the integration time to ∼10 s in the absence of larger population
sizes to prevent camera saturation allows for detection down to ∼50 cells. Boxes represent the mean values of three trials, reported with the standard
error of the mean.

using ∼30 s integration times.1 It was also demonstrated that
following subcutaneous injection the lower level for detection
was 25000 cells when using increased integration times (∼10
min) [Fig. 5(b)].
Intraperitoneal injections of ∼1 × 107 holux-expressing cells
yielded a disparate bioluminescent profile from that of the subcutaneous injections. The largest total flux was immediately
measured following substrate injection at a rate of 3.6 ( ±
0.2) × 105 p/s. Following this initial light output, the total flux
continued to trend downward over the remainder of the assay
[Fig. 5(c)]. The greatest decrease, presumably from dispersion
of the cells following injection, occurred during the first 15 min,
during which the total flux decreased from the maxima to 2.4
( ± 0.2) × 105 p/s. After this time, the rate of bioluminescent
production remained relatively flat, decreasing ∼67000 p/s by
the final time point of the 60 min assay. Due to the diffusion of
cells within the intraperitoneal cavity following injection and the
increased amount of scattering and absorption associated with

Fig. 4 Cells expressing GFP were visible down to population sizes
of ∼5 × 105 cells. Boxes represent the mean values of three trials,
reported with the standard error of the mean.
Journal of Biomedical Optics

intraperitoneal imaging, pseudocolor images obtained using a
60 s integration time were not as well defined as those from the
subcutaneous injections despite the injection of a higher number
of cells [Figs. 6(a) and 6(c)]. The expression value differences
(in p/s) that lead to these changes in pseudocolor representation
are presented in Table 4.

3.5 In Vivo Luc Detection
Subcutaneous injection of ∼5 × 105 Luc-containing cells produced a bell curve of bioluminescent production. Immediately
following intraperitoneal injection of 150 mg D-luciferin/kg,
the average total flux from each injection site was 1.0 ( ± 0.2)
× 106 p/s. Total flux then rapidly increased over the next 40 min
to a maximum of 2.0 ( ± 0.5) × 108 p/s before declining for the
remainder of the 60 min assay. Along with the increased flux
values were increased error ranges at each time point as compared to the holux-expressing cell line. Standard error of each
reading averaged 4.0 ( ± 0.5) × 107 p/s [Fig. 5(d)]. Visual detection of a signal was never problematic, with a 1 s integration
providing ample exposure for facile visual representation of the
subcutaneous injection site [Fig. 6(b)]. With the system under
the control of the CMV promoter, the minimum detectable cell
number was determined to be 2500 under subcutaneous imaging
conditions [Fig. 5(e)].
Intraperitoneal injections of ∼1 × 106 Luc-expressing cells
produced a much different time dependent bioluminescent expression profile than that obtained following subcutaneous injections [compare Fig. 5(f) to Fig. 5(d)]. The magnitude of
bioluminescent flux notwithstanding, the time dependent bioluminescent profile following intraperitoneal injection of Lucexpressing cells yielded a profile similar to that obtained following intraperitoneal injections of holux-expressing cells [compare
Fig. 5(f) to Fig. 5(c)]. The highest total flux occurred immediately after intraperitoneal injection of 150 mg D-luciferin/kg at
1.6 ( ± 0.3) × 109 p/s. The bioluminescent flux then quickly
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Fig. 5 Comparison of in vivo bioluminescence for holux and Luc cells. (a) The bioluminescent signal following subcutaneous injection of holuxexpressing cells remains relatively stable following injection and (b) is detectable down to a minimum of ∼25000 cells. (c) Signal dynamics are
significantly altered, but of approximately the same strength following intraperitoneal injection. (d) Total flux from subcutaneous injection of Lucexpressing cells is significantly higher, and (e) as such is detectable down to ∼2500 cells. (f) Bioluminescent output from intraperitoneal injected
Luc-expressing cells expressed peak flux immediately following D-luciferin injection, but then quickly diminished over the remainder of the assay.

decreased to 1.0 ( ± 0.1) × 109 p/s by 10 min post-luciferin injection. For the remaining 50 min of the assay the total flux
remained relatively constant, averaging 9.2 ( ± 0.2) × 108
p/s. As with the holux-expressing cells, integration time had
to be extended to obtain a representative visual image of the
intraperitoneal injection site. Intraperitoneal injection of ∼1 ×
106 Luc-expressing cells, followed by immediate imaging postD-luciferin injection using a 10 s integration time, produced a
pseudocolor visual representation similar to the pseudocolor images obtained using a 60 s integration time following injection of
∼1 × 107 holux-expressing cells, but did not produce images that
were as well defined as those following subcutaneous injection
[Figs. 6(b) and 6(d)]. This is presumably due to the increases in
absorbance and scattering associated with injection into the intraperitoneal cavity. A summary of the differences between Luc
expression in vivo or in vitro following either a subcutaneous or
intraperitoneal injection can be found in Table 4.
Journal of Biomedical Optics

4 Discussion
There have been numerous demonstrations of the bioluminescent and fluorescent profiles obtained in culture or small animal
imaging when employing the Luc or GFP proteins as targets.
The variety and scope of published literature utilizing these or
versions of these reporters is testament to their usefulness, as
well as the expression strategies to which they can be adapted
within the confines of a particular experimental design. To aid in
the comparison of the three different systems under conditions
that are as uniform and comparable as could be achieved, each
was expressed in the same cellular background (HEK293) and
placed under the control of identical cytomegalovirus (CMV)
promoters. The use of identical promoters should encourage
similar levels of expression when each construct is expressed
in the HEK293 cell line.12 However, in the holux cell line,
although luxAB is driven by the CMV promoter, the luxC
and luxE genes are instead under the control of the human
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Fig. 6 Comparison of pseudocolor images of subcutaneously and intraperitonealy injected holux and Luc Cells. Subcutaneously injected (a) holuxor (b) Luc-expressing cells are capable of presenting relatively similar images despite the large differences in total flux from each reporter system
if the integration time is increased from 1 s (Luc) to 60 s (holux). Similar increases must be made to maintain uniform representative detection
following intraperitoneal injection of the (c) holux and (d) Luc cells as well, with the holux system requiring a 60 s integration time to achieve similar
pseudocolor patterning as a 10 s integration of the Luc system.

elongation factor 1 alpha (Ef1α) promoter. Because the previously published demonstration of holux function was designed
in this manner,1 it was not subjected to any modification prior
to expression in order to allow for consistent comparison with
the previously published results.
As expected, bioluminescence from the Luc system was detectable at lower cell concentrations and displayed a significantly larger total flux than equal numbers of holux-containing
cells in the mouse imaging experiments and its detection level
was lower than both the lux and GFP reporters in the cell culture
imaging scenarios. Under conditions where only small populations of Luc-expressing cells were assayed in cell culture, as
few as 50 Luc cells/well were visible [Figs. 1(c) and 3(b)], compared with a minimum of 15000 cells/well for the holux system
[Fig. 1(a)], and 5.0 × 105 cells/well in the GFP system when cells

Journal of Biomedical Optics

were imaged in PBS [Figs. 1(e) and 4]. The need to use PBS as a
liquid medium to detect lower GFP-expressing cell numbers due
to the autofluorescence from the cell culture medium represents
a crucial problem with using fluorescent systems for prolonged
cell culture imaging. The lack of medium components such as
serum and nutrients required for low-level fluorescent detection
does not promote continued cellular growth, thereby preventing
potential autonomous fluorescent monitoring without regular
medium changes. The inclusion of these compounds can prevent this, but increases the minimum detectable cell number
beyond 1 million cells/well, and therefore could not be detected
under our imaging conditions.
Another approach to overcome the poor sensitivity of GFP in
culture is to use an alternate cell line capable of more efficiently
expressing the reporter. It has previously been demonstrated that
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Table 3 GFP-expressing cells could be significantly differentiated from background fluorescence detection at all time points following plating when
greater than ∼5 × 105 cells were present. Detection of ∼5 × 105 cells became possible nine hours after plating, while detection of less than ∼5
× 105 cells was not possible at any of the time points surveyed. Green boxes represent time points where the indicated cell population was able to
be significantly distinguishable from background. Red hatched boxes represent time points where the indicated cell population was not significantly
distinguishable from background light detection.

GFP expression under the control of the CMV promoter in the
MCF-7 breast cancer cell line is capable of being detected at
lower numbers of GFP-expressing cells/well.13 However, these
experiments were conducted in wells of significantly smaller
surface area (0.32 cm2 as compared to 1.9 cm2 ) than used in
these experiments. When the results from both experiments are
normalized to media volume, this corresponds to a lower detection level of ∼250 cells/μl using MCF-7 cells compared to
∼500 cells/μl when expressed in HEK293 cells.
Our results demonstrate, however, that the use of bioluminescence rather than fluorescence as an imaging modality completely circumvents this problem. However, there is a large
difference in the bioluminescent output levels and imaging
strategies between the holux and Luc systems. The holux system
has the advantage of not requiring addition of a substrate to elicit
bioluminescent production, therefore allowing for completely

autonomous bioluminescent readings that should routinely correlate with cell number, regardless of time. The disadvantage
of the holux system is that it is significantly less efficient than
the Luc system. While the average radiance of ∼1 × 106 holux
cells had a peak value of 6400 p/s/cm2 /sr, this is comparable
to the peak average radiance of only ∼100 HEK-Luc cells/well
(although this number of cells/well cannot be reliably detected
following the initial bioluminescent burst following substrate
amendment as shown in Table 2). Therefore, detection of small
numbers of cells in culture is best suited to a Luc-based reporter system, especially if the production of light is only to be
monitored over short time periods. However, if working with
larger cell populations, the use of a holux-based reporter system
gives the benefit of continuous bioluminescent output, and is not
dependent on the addition of luciferin to the cell culture medium.
Regardless of which reporter system is employed, the use of a

Table 4 Summary of comparisons between the holux, Luc, and GFP reporter systems under in vitro and in vivo imaging conditions.

in vitro
Maximum Average Radiance
(p/s/cm2 /sr)

Time To Peak Average
Radiance (hr)

Range Of Average
Radiance (p/s/cm2 /sr) Average Error (p/s/cm2 /sr)

Minimum Detectable
Cell Number Across All
Time Points

0.0064 ( ± 0.0001) × 106

16

0.046 × 105

0.0058 ( ± 0.0004) × 104

1.0 × 105

Luc

88.0 ( ± 4.0) × 106

0.17

890 × 105

290 ( ± 60) × 104

0.00250 × 105

GFP

6.6 ( ± 0.1) × 106

22

6.0 × 105

7.3 ( ± 0.3) × 104

7.5 × 105

holux

in vivo
Subcutaneous

holux
Luc

Maximum Total Flux (p/s)

Average Error (p/s)

Number Of Cells
Injected

Integration Time (sec)

Minimum Detectable
Cell Number

0.15 ( ± 0.02) × 106

0.16 ( ± 0.03) × 105

5.0 × 106

60

25.0 × 103

200 ( ± 20) × 106

400 ( ± 50) × 105

0.5 × 106

1

2.5 × 103

Intraperitoneal

holux
Luc

Maximum Total Flux (p/s)

Average Error (p/s)

Number Of Cells Injected

Integration Time (sec)

0.036 ( ± 0.002) × 107

0.070 ( ± 0.022) × 105

1.0 × 107

60

160 ( ± 30) × 107

580 ( ± 210) × 105

0.1 × 107
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bioluminescent system (either holux or Luc) has the advantage
of low background detection when compared with the use of a
fluorescent system such as GFP in a medium-based cell culture
setting.
When applied to small animal imaging, the same general
benefits for each reporter system are reiterated. The major disadvantage of working with GFP or alternate fluorescent reporter
systems in an animal model is the relatively high level of background fluorescence resulting from excitation of endogenous
chromophoric material within the subject tissue. The use of a
bioluminescent reporter helps to overcome this disadvantage due
to the low levels of background autoluminescence in mammalian
tissues.14 While Luc-based systems have most often been utilized for small animal imaging, the holux system provides a distinct advantage for near-surface target visualization. Although
not as bright as the Luc system [total flux averaged 1.5 ( ± 0.2)
× 105 p/s for a subcutaneous injection of ∼5 × 106 HEK293
holux cells versus an overall average total flux of 1.4 ( ± 0.2)
× 108 p/s for a subcutaneous injection of ∼5 × 105 Luc cells],
the bioluminescent profile of the holux-containing cells was relatively flat over the full course of the assay, while the bioluminescent profile of the Luc-containing cells varied greatly following
substrate injection due to the nonstandard rate of substrate uptake by Luc-containing cells, the depletion of the administered
luciferin substrate, and the lack of coordinated bioluminescent
expression from reporter cells exposed to luciferin. In addition,
the act of administering luciferin encompasses its own set of
concerns. It has been well documented that the bioluminescent
profile can be altered depending on the route of substrate administration for Luc-based systems,15 with each route having
different uptake rates throughout the body.16 Also of concern,
the process of substrate injection allows for the introduction of
error due to differences in the efficiency of each injection and/or
the possibility of potential injection failure (i.e., injection into the
bowel during intraperitoneal administration).15 Any changes in
the quality of the luciferin over time during multiple injections17
as well as the possible introduction of tissue damage that can
prohibit further injections create additional concern.18 For largescale experiments, the cost of luciferin must also be taken into
consideration, as it is an expensive substrate. Therefore, the
use of a holux-based reporter is more simplistic and economical and may provide more reliable results if relatively large
numbers of cells are being imaged close to the surface of the
subject.
While previous reports have suggested that detection of a
single cell expressing the luc reporter gene is possible in the
4T1 mouse mammary tumor line,19 we determined that a minimum of 2500 cells were required when the Luc system was expressed in HEK293 cells under the control of a CMV promoter
[Fig. 5(e)]. Despite the increase in cells required for detection
under our expression conditions, this number was still well below that required for detection of the holux-expressing cells
[Fig. 5(b)]. The diminished performance of the holux cells compared to Luc-containing cells during both minimal detection
level testing and intraperitoneal injection demonstrates that the
associated benefits of the holux system are of little value if they
cannot be easily detected under experimentally relevant imaging conditions. In cases where deep tissue imaging is required,
the use of a Luc-based system can be advantageous despite the
concerns associated with substrate addition, especially since its
Journal of Biomedical Optics

use in these types of experiments is widespread and well documented. Whether subcutaneous or intraperitoneal injection is
chosen as the route of administration, it is important to realize
that the decreased efficiency of the holux system as compared
to the Luc system necessitates an increase in integration time
to obtain similar detection levels (Fig. 6). The amount of time
required for signal detection must be considered in the context
of a given experiment to determine if detection of the holux signal at a level similar to what a researcher may be accustomed to
using a Luc-based system is acceptable.
The greatest advantages of the new holux system, however,
are the ability for researchers to integrate its use alongside other
established fluorescent and bioluminescent systems and the ability to exploit the unique autonomous nature of lux bioluminescent expression with novel detection methods. Because the presence of fluorescently labeled cells would not be detected under
bioluminescent imaging conditions (i.e., in the absence of an excitation signal), the location and size of bioluminescent signals
could be determined and then differentiated from any fluorescent signals detected following administration of the excitation
signal. In addition, the holux signal could be determined prior
to substrate injection in conjunction with alternative bioluminescent reporter systems to sequentially determine the location
and size of differentially labeled cell populations within a living
host. Alternatively, the autonomous nature of lux bioluminescent expression could allow it to be paired with miniaturized
integrated circuit microluminometers20 that could one day be
implanted under the skin of an animal subject, allowing for realtime detection of signal without the need for external imaging
equipment. This possibility opens the door for development of
integrated biofeedback circuits that can autonomously monitor
and subsequently react to numerous in vivo disease conditions.
So while the introduction of a holux imaging target certainly
does not displace the use of currently available fluorescent and
bioluminescent imaging targets, it can overcome some of the
shortcomings of these systems and integrates well with them as
an additional tool for noninvasive imaging.
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